INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q4 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,783 | +22.4% | 10,407,216 | +2.3% | 0.04% | +30.0% |
| Q2 2023 | $214,637 | +26.1% | 10,172,296 | +1.9% | 0.03% | +20.0% |
| Q1 2023 | $170,195 | -14.6% | 9,982,064 | +0.0% | 0.02% | -21.9% |
| Q4 2022 | $199,358 | -99.9% | 9,977,911 | +4.5% | 0.03% | -5.9% |
| Q3 2022 | $205,670,000 | -35.7% | 9,548,247 | -41.1% | 0.03% | -15.0% |
| Q2 2022 | $319,910,000 | -14.2% | 16,222,623 | +2.3% | 0.04% | +5.3% |
| Q1 2022 | $372,669,000 | -10.7% | 15,858,261 | +3.5% | 0.04% | 0.0% |
| Q4 2021 | $417,350,000 | +2.8% | 15,321,204 | +3.9% | 0.04% | 0.0% |
| Q3 2021 | $405,951,000 | -0.8% | 14,740,432 | +2.6% | 0.04% | 0.0% |
| Q2 2021 | $409,047,000 | +6.3% | 14,372,685 | +27.2% | 0.04% | -2.6% |
| Q1 2021 | $384,965,000 | +19.8% | 11,302,545 | +17.1% | 0.04% | +18.2% |
| Q4 2020 | $321,325,000 | +5.2% | 9,652,304 | +1.6% | 0.03% | -5.7% |
| Q3 2020 | $305,306,000 | +15.9% | 9,499,250 | -0.7% | 0.04% | +6.1% |
| Q2 2020 | $263,483,000 | +135.6% | 9,567,299 | +37.1% | 0.03% | +83.3% |
| Q1 2020 | $111,832,000 | -28.3% | 6,976,409 | +6.8% | 0.02% | -10.0% |
| Q4 2019 | $155,955,000 | +30.1% | 6,530,775 | -3.9% | 0.02% | +17.6% |
| Q3 2019 | $119,901,000 | -33.6% | 6,797,128 | -3.7% | 0.02% | -32.0% |
| Q2 2019 | $180,684,000 | -21.2% | 7,057,967 | -10.5% | 0.02% | -26.5% |
| Q1 2019 | $229,231,000 | +101.4% | 7,885,495 | -9.1% | 0.03% | +78.9% |
| Q4 2018 | $113,834,000 | -46.4% | 8,676,398 | -17.4% | 0.02% | -38.7% |
| Q3 2018 | $212,315,000 | -28.2% | 10,500,244 | -16.0% | 0.03% | -31.1% |
| Q2 2018 | $295,613,000 | +4.3% | 12,499,490 | -0.6% | 0.04% | 0.0% |
| Q1 2018 | $283,308,000 | -30.3% | 12,580,281 | -3.4% | 0.04% | -31.8% |
| Q4 2017 | $406,232,000 | +1.2% | 13,028,622 | +1.3% | 0.07% | -4.3% |
| Q3 2017 | $401,351,000 | +127.2% | 12,859,684 | +24.9% | 0.07% | +115.6% |
| Q2 2017 | $176,654,000 | -6.7% | 10,294,551 | -4.8% | 0.03% | -8.6% |
| Q1 2017 | $189,252,000 | +36.1% | 10,808,219 | +2.9% | 0.04% | +25.0% |
| Q4 2016 | $139,007,000 | -4.6% | 10,506,925 | +4.7% | 0.03% | -3.4% |
| Q3 2016 | $145,750,000 | +47.7% | 10,037,872 | +0.3% | 0.03% | +38.1% |
| Q2 2016 | $98,704,000 | -19.2% | 10,010,522 | +3.8% | 0.02% | -19.2% |
| Q1 2016 | $122,203,000 | -27.4% | 9,645,081 | +4.0% | 0.03% | -25.7% |
| Q4 2015 | $168,362,000 | +0.3% | 9,276,146 | +2.6% | 0.04% | -5.4% |
| Q3 2015 | $167,899,000 | -20.5% | 9,041,389 | +4.5% | 0.04% | -14.0% |
| Q2 2015 | $211,322,000 | +21.4% | 8,653,627 | +3.4% | 0.04% | +19.4% |
| Q1 2015 | $174,120,000 | +2516.4% | 8,371,147 | +1845.9% | 0.04% | +3500.0% |
| Q4 2014 | $6,655,000 | +27.2% | 430,187 | +7.3% | 0.00% | 0.0% |
| Q3 2014 | $5,233,000 | +292.6% | 401,000 | +472.6% | 0.00% | – |
| Q1 2014 | $1,333,000 | – | 70,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |